Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Josh Schimmer is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/01/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/01/2024 | BBIO | Buy Now | BridgeBio Pharma | $25.90 | 170.27% | $70 → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 06/21/2024 | INSM | Buy Now | Insmed | $66.34 | 13.05% | $42 → $75 | Maintains | Outperform | Get Alert |
| 06/21/2024 | CABA | Buy Now | Cabaletta Bio | $7.81 | 540.2% | $50 → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | $29.26 | 94.81% | $44 → $57 | Maintains | Outperform | Get Alert |
| 06/20/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | $29.26 | 105.06% | $60 → $60 | Reiterates | Overweight → Overweight | Get Alert |
| 06/17/2024 | ZURA | Buy Now | Zura Bio | $3.62 | — | — | Reiterates | → Overweight | Get Alert |
| 06/12/2024 | RNA | Buy Now | Avidity Biosciences | $40.21 | 11.9% | $40 → $45 | Maintains | Outperform | Get Alert |
| 06/12/2024 | ZURA | Buy Now | Zura Bio | $3.62 | — | — | Initiates | → Overweight | Get Alert |
| 05/28/2024 | BBIO | Buy Now | BridgeBio Pharma | $25.90 | 170.27% | $70 → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 05/14/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $46.30 | 40.39% | → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 05/09/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $34.16 | 17.1% | → $40 | Reiterates | Overweight → Overweight | Get Alert |
| 05/09/2024 | JANX | Buy Now | Janux Therapeutics | $41.72 | 139.69% | → $100 | Reiterates | Overweight → Overweight | Get Alert |
| 05/06/2024 | CGON | Buy Now | CG Oncology | $31.72 | 136.44% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 05/03/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | $29.26 | 105.06% | → $60 | Reiterates | Overweight → Overweight | Get Alert |
| 05/02/2024 | CGON | Buy Now | CG Oncology | $31.72 | 136.44% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 04/10/2024 | XENE | Buy Now | Xenon Pharmaceuticals | $37.69 | 72.46% | → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 04/10/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | $29.26 | 105.06% | → $60 | Reiterates | Overweight → Overweight | Get Alert |
| 03/20/2024 | JANX | Buy Now | Janux Therapeutics | $41.72 | 139.69% | → $100 | Initiates | → Overweight | Get Alert |
| 03/19/2024 | BBIO | Buy Now | BridgeBio Pharma | $25.90 | 170.27% | $60 → $70 | Maintains | Overweight | Get Alert |
| 03/13/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | $29.26 | 105.06% | → $60 | Reiterates | Overweight → Overweight | Get Alert |
| 03/11/2024 | BBIO | Buy Now | BridgeBio Pharma | $25.90 | 131.66% | $50 → $60 | Maintains | Overweight | Get Alert |
| 03/04/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $34.16 | 17.1% | $35 → $40 | Maintains | Overweight | Get Alert |
| 03/04/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $46.30 | 40.39% | $50 → $65 | Maintains | Overweight | Get Alert |
| 02/29/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $34.16 | 2.46% | → $35 | Reiterates | Overweight → Overweight | Get Alert |
| 02/27/2024 | RCKT | Buy Now | Rocket Pharmaceuticals | $20.59 | 215.69% | $65 → $65 | Maintains | Overweight | Get Alert |
| 02/20/2024 | CGON | Buy Now | CG Oncology | $31.72 | 136.44% | → $75 | Initiates | → Overweight | Get Alert |
| 02/02/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $46.30 | 7.99% | → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 01/22/2024 | BBIO | Buy Now | BridgeBio Pharma | $25.90 | 93.05% | → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 01/16/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | $29.26 | 105.06% | $55 → $60 | Maintains | Overweight | Get Alert |
| 01/02/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | $29.26 | 87.97% | $35 → $55 | Maintains | Overweight | Get Alert |
| 12/21/2023 | RLYB | Buy Now | Rallybio | $1.41 | 963.83% | $18 → $15 | Maintains | Outperform | Get Alert |
| 12/20/2023 | LBPH | Buy Now | Longboard Pharmaceuticals | $29.26 | 19.62% | → $35 | Reiterates | Overweight → Overweight | Get Alert |
| 12/19/2023 | CRNX | Buy Now | Crinetics Pharmaceuticals | $46.30 | 7.99% | → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 12/19/2023 | LBPH | Buy Now | Longboard Pharmaceuticals | $29.26 | 19.62% | → $35 | Reiterates | Overweight → Overweight | Get Alert |
| 12/13/2023 | KRYS | Buy Now | Krystal Biotech | $182.27 | -1.25% | $160 → $180 | Maintains | Overweight | Get Alert |
| 12/04/2023 | CRNX | Buy Now | Crinetics Pharmaceuticals | $46.30 | 7.99% | → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 11/27/2023 | MIRM | Buy Now | Mirum Pharmaceuticals | $34.16 | 46.37% | → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 11/10/2023 | VTYX | Buy Now | Ventyx Biosciences | $2.28 | 119.3% | $43 → $5 | Downgrade | Outperform → In-Line | Get Alert |
| 11/07/2023 | KRYS | Buy Now | Krystal Biotech | $182.27 | -12.22% | → $160 | Reiterates | Overweight → Overweight | Get Alert |
| 10/24/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $21.34 | 49.95% | → $32 | Initiates | → Overweight | Get Alert |
| 10/24/2023 | LBPH | Buy Now | Longboard Pharmaceuticals | $29.26 | 19.62% | $16 → $35 | Assumes | → Overweight | Get Alert |
| 10/24/2023 | XENE | Buy Now | Xenon Pharmaceuticals | $37.69 | — | — | Assumes | → Overweight | Get Alert |
| 10/24/2023 | RCKT | Buy Now | Rocket Pharmaceuticals | $20.59 | 215.69% | → $65 | Initiates | → Overweight | Get Alert |
| 10/24/2023 | BBIO | Buy Now | BridgeBio Pharma | $25.90 | 93.05% | → $50 | Initiates | → Overweight | Get Alert |
| 10/24/2023 | KRYS | Buy Now | Krystal Biotech | $182.27 | -12.22% | → $160 | Initiates | → Overweight | Get Alert |
| 09/07/2023 | INSM | Buy Now | Insmed | $66.34 | -36.69% | $32 → $42 | Maintains | Outperform | Get Alert |
| 06/14/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | → $40 | Downgrade | Outperform → In-Line | Get Alert |
| 06/06/2023 | ERAS | Buy Now | Erasca | $2.45 | 348.98% | $20 → $11 | Maintains | Outperform | Get Alert |
| 05/22/2023 | RNA | Buy Now | Avidity Biosciences | $40.21 | -50.26% | → $20 | Upgrade | In-Line → Outperform | Get Alert |
| 04/19/2023 | BBIO | Buy Now | BridgeBio Pharma | $25.90 | 54.44% | → $40 | Initiates | → Outperform | Get Alert |
| 04/18/2023 | BLU | Buy Now | BELLUS Health | — | — | $24 → $14.75 | Downgrade | Outperform → In-Line | Get Alert |
| 03/30/2023 | BCEL | Buy Now | Atreca | $0.07 | 2105.88% | $2 → $1.5 | Downgrade | Outperform → In-Line | Get Alert |
| 11/14/2022 | NBIX | Buy Now | Neurocrine Biosciences | $140.11 | -7.22% | $140 → $130 | Downgrade | Outperform → In-Line | Get Alert |
| 10/17/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.06K | -28.1% | → $760 | Downgrade | Outperform → In-Line | Get Alert |
| 09/23/2022 | SPRO | Buy Now | Spero Therapeutics | $1.27 | 529.72% | $2 → $8 | Upgrade | In-Line → Outperform | Get Alert |
| 05/04/2022 | SPRO | Buy Now | Spero Therapeutics | $1.27 | 57.43% | $40 → $2 | Downgrade | Outperform → In-Line | Get Alert |
| 03/15/2022 | ZYME | Buy Now | Zymeworks | $8.61 | 74.22% | → $15 | Initiates | → Outperform | Get Alert |
| 12/13/2021 | BLU | Buy Now | BELLUS Health | — | — | — | Maintains | Outperform | Get Alert |
| 11/15/2021 | VTYX | Buy Now | Ventyx Biosciences | $2.28 | 2092.98% | — | Initiates | → Outperform | Get Alert |
| 06/01/2021 | TALS | Buy Now | Talaris Therapeutics | — | — | → $350 | Initiates | → Outperform | Get Alert |
